The vast majority of evidence comes from animal studies, which are promising but cannot be directly extrapolated to human outcomes
Our approach allows us to provide competitive prices, giving our members the best value for their money
Side effects can be severe enough that people stop taking the medications
The medicinal-chemistry programme that produced cagrilintide, described by Kruse and colleagues in the Journal of Medicinal Chemistry in 2021, addressed this by re-engineering the amylin backbone with structural elements borrowed from calcitonin (a related, non-aggregating peptide) and attaching a fatty-acid side chain that enables reversible binding to serum albumin [1]
Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone
These changes were partially moderated by changes in brain morphometry, underscoring the interrelationship between weight and brain structure/ function